RJR1.F
Stereotaxis, Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
1.19
▼ 0.02 (1.33%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.19
Prev close
1.20
Day high
1.19
Day low
1.19
Volume
200
Market cap
$118.84M
P/E (TTM)
—
52W range
1.07 – 3.00
Day trading desk
Gap from prior close
-1.33%
Prior close 1.20
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
1.19 – 1.19
Position in range
—
—
ATR (14D)
0.02
2.02% of price
Prior day high
1.20
PDH
Prior day low
1.20
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 69
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.37%
+2.6%
1M
-4.51%
-7.8%
3M
-27.59%
-30.0%
6M
-33.37%
-45.3%
YTD
-37.91%
-49.9%
1Y
-50.58%
-70.7%
3Y
-22.99%
-98.0%
5Y
-75.89%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on RJR1.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
21.19M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 1, 26 | MENAWAT ARUN SWARUP PH.D. Director |
STOCK | 43.10K | $0 | Direct |
| Jul 1, 26 | CURET MYRIAM MCADAMS Director |
STOCK | 43.10K | $0 | Direct |
| Jul 1, 26 | FISCHEL NATHAN Director and Beneficial Owner of more than 10% of a Class of Security |
STOCK | 43.10K | $0 | Direct |
| Jul 1, 26 | LEVIN ROSS B. Director |
STOCK | 43.10K | $0 | Direct |
| Jul 1, 26 | BENFER DAVID W Director |
STOCK | 43.10K | $0 | Direct |
| Jul 1, 26 | SHAMIR NACHUM Director |
STOCK | 43.10K | $0 | Direct |
| Jan 2, 26 | MENAWAT ARUN SWARUP PH.D. Director |
STOCK | 46.95K | $0 | Direct |
| Jan 2, 26 | FISCHEL NATHAN Director and Beneficial Owner of more than 10% of a Class of Security |
STOCK | 46.95K | $0 | Direct |
| Jan 2, 26 | LEVIN ROSS B. Director |
STOCK | 46.95K | $0 | Direct |
| Jan 2, 26 | CURET MCADAMS MYRIAM J Director |
STOCK | 46.95K | $0 | Direct |
| Jan 2, 26 | BENFER DAVID W Director |
STOCK | 46.95K | $0 | Direct |
| Jan 2, 26 | SHAMIR NACHUM Director |
STOCK | 46.95K | $0 | Direct |
| Nov 17, 25 | ISAAC PAUL J Director |
BUY | 30.00K | $66.60K | |
| Jul 1, 25 | MENAWAT ARUN SWARUP PH.D. Director |
STOCK | 43.67K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BENFER DAVID W |
Director | 771.93K | Stock Award(Grant) |
CURET MCADAMS MYRIAM J |
Director | 392.06K | Stock Award(Grant) |
CURET MYRIAM MCADAMS |
Director | 435.16K | Stock Award(Grant) |
FISCHEL NATHAN |
Director and Beneficial Owner of more than 10% of a Class of Security | 14.40M | Stock Award(Grant) |
ISAAC PAUL J |
Director | — | Purchase |
LEVIN ROSS B. |
Director | 621.25K | Stock Award(Grant) |
MENAWAT ARUN SWARUP PH.D. |
Director | 1.04M | Stock Award(Grant) |
SHAMIR NACHUM |
Director | 179.33K | Stock Award(Grant) |
Fundamentals
Market cap$118.84M
Enterprise value$120.36M
Revenue (TTM)$30.07M
Gross profit$16.71M
EBITDA$-18.06M
Net income$-23.59M
EPS (TTM)$-0.21
Free cash flow$-8.83M
Total cash$10.49M
Total debt$5.17M
Book value / share$0.11
Shares outstanding100.20M
Float65.54M
Short % of float—
Dividend yield—
Beta (5Y)1.40
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book11.09
EV / revenue4.00
EV / EBITDA-6.67
Gross margin55.57%
Operating margin-59.56%
Profit margin-74.24%
Return on equity-184.27%
Return on assets-25.38%
Debt / equity29.60
Current ratio1.42
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $32.38M | $26.92M | $26.77M | $28.15M | +20.3% |
| Operating revenue | $32.38M | $26.92M | $26.77M | $28.15M | +20.3% |
| Cost of revenue | $15.31M | $12.32M | $11.91M | $9.68M | +24.2% |
| Gross profit | $17.07M | $14.59M | $14.86M | $18.47M | +17.0% |
| Research & development | $9.38M | $9.76M | $10.27M | $10.56M | -3.9% |
| Selling, general & admin | $30.29M | $29.57M | $26.43M | $26.69M | +2.4% |
| Total operating expense | $39.18M | $39.33M | $36.70M | $37.25M | -0.4% |
| Operating income | -$22.11M | -$24.74M | -$21.84M | -$18.78M | +10.6% |
| Net interest income | $467.00K | $694.00K | $1.10M | $484.00K | -32.7% |
| Pre-tax income | -$21.64M | -$24.05M | -$20.71M | -$18.29M | +10.0% |
| Net income | -$21.64M | -$24.05M | -$20.71M | -$18.29M | +10.0% |
| Net income to common | -$22.91M | -$25.35M | -$22.06M | -$19.64M | +9.6% |
| Basic EPS | -0.25 | -0.30 | -0.27 | -0.26 | +16.7% |
| Diluted EPS | -0.25 | -0.30 | -0.27 | -0.26 | +16.7% |
| EBIT | -$22.11M | -$24.74M | -$21.84M | -$18.78M | +10.6% |
| EBITDA | -$20.56M | -$23.77M | -$21.24M | -$18.35M | +13.5% |
| Basic shares | 90.96M | 85.18M | 80.70M | 76.06M | +6.8% |
| Diluted shares | 90.96M | 85.18M | 80.70M | 76.06M | +6.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $13.42M | $12.22M | $19.82M | $8.59M | +9.9% |
| Cash & short-term investments | $13.42M | $12.22M | $19.82M | $28.43M | +9.9% |
| Accounts receivable | $5.85M | $3.82M | $3.82M | $5.09M | +52.9% |
| Inventory | $9.57M | $8.33M | $8.43M | $7.88M | +14.8% |
| Total current assets | $33.85M | $26.44M | $33.27M | $43.25M | +28.0% |
| Property, plant & equipment | $7.93M | $9.06M | $8.29M | $9.21M | -12.4% |
| Goodwill & intangibles | $10.19M | $11.12M | $0 | — | -8.4% |
| Total assets | $52.25M | $46.72M | $41.91M | $53.41M | +11.8% |
| Total current liabilities | $22.36M | $21.60M | $13.25M | $14.29M | +3.5% |
| Total debt | $5.44M | $6.01M | $5.49M | $5.86M | -9.5% |
| Total liabilities | $33.53M | $35.29M | $19.99M | $21.48M | -5.0% |
| Retained earnings | -$583.37M | -$561.73M | -$537.68M | -$516.97M | -3.9% |
| Shareholder equity | $18.72M | $11.43M | $21.92M | $31.93M | +63.8% |
| Working capital | $11.49M | $4.84M | $20.02M | $28.95M | +137.5% |
| Net tangible assets | $8.53M | $310.00K | $21.92M | $31.93M | +2,651.0% |
| Shares issued | 95.34M | 85.33M | 80.95M | 74.87M | +11.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$21.64M | -$24.05M | -$20.71M | -$18.29M | +10.0% |
| Depreciation & amortisation | $1.55M | $969.00K | $595.00K | $429.00K | +60.5% |
| Stock-based compensation | $9.85M | $10.26M | $10.62M | $10.58M | -4.0% |
| Change in working capital | -$5.62M | $2.50M | $612.00K | -$1.10M | -324.4% |
| Operating cash flow | -$13.69M | -$8.50M | -$9.14M | -$8.41M | -61.1% |
| Capital expenditure | -$93.00K | -$34.00K | -$366.00K | -$2.38M | -173.5% |
| Investing cash flow | -$93.00K | $74.00K | $19.77M | -$22.09M | -225.7% |
| Financing cash flow | $14.76M | $297.00K | $81.00K | $220.00K | +4,870.7% |
| Free cash flow | -$13.78M | -$8.53M | -$9.51M | -$10.79M | -61.5% |
| End cash position | $13.42M | $12.44M | $20.56M | $9.86M | +7.9% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $6.29M | $8.64M | $7.46M | $8.80M | $7.47M | -27.2% |
| Operating revenue | $6.29M | $8.64M | $7.46M | $8.80M | $7.47M | -27.2% |
| Cost of revenue | $2.50M | $4.32M | $3.36M | $4.22M | $3.41M | -42.1% |
| Gross profit | $3.79M | $4.33M | $4.10M | $4.58M | $4.06M | -12.3% |
| Research & development | $2.40M | $2.71M | $2.55M | $1.78M | $2.35M | -11.5% |
| Selling, general & admin | $7.38M | $7.27M | $8.11M | $7.27M | $7.64M | +1.5% |
| Total operating expense | $9.78M | $9.98M | $10.66M | $8.56M | $9.99M | -2.0% |
| Operating income | -$5.98M | -$5.65M | -$6.56M | -$3.98M | -$5.93M | -5.9% |
| Net interest income | $125.00K | $118.00K | $91.00K | $152.00K | $106.00K | +5.9% |
| Pre-tax income | -$5.86M | -$5.53M | -$6.46M | -$3.83M | -$5.82M | -6.0% |
| Net income | -$5.86M | -$5.53M | -$6.46M | -$3.83M | -$5.82M | -6.0% |
| Net income to common | -$6.17M | -$5.85M | -$6.79M | -$4.14M | -$6.14M | -5.5% |
| Basic EPS | -0.06 | -0.06 | -0.07 | -0.05 | -0.07 | 0.0% |
| Diluted EPS | -0.06 | -0.06 | -0.07 | -0.05 | -0.07 | 0.0% |
| EBIT | -$5.98M | -$5.65M | -$6.56M | -$3.98M | -$5.93M | -5.9% |
| EBITDA | -$5.59M | -$5.25M | -$6.17M | -$3.58M | -$5.56M | -6.3% |
| Basic shares | 98.89M | 95.97M | 92.01M | 87.95M | 87.77M | +3.0% |
| Diluted shares | 98.89M | 95.97M | 92.01M | 87.95M | 87.77M | +3.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.62M | $13.42M | $10.51M | $6.97M | $10.60M | +8.9% |
| Cash & short-term investments | $14.62M | $13.42M | $10.51M | $6.97M | $10.60M | +8.9% |
| Accounts receivable | $5.30M | $5.85M | $5.33M | $4.39M | $4.32M | -9.3% |
| Inventory | $10.49M | $9.57M | $10.15M | $9.61M | $9.81M | +9.7% |
| Total current assets | $36.03M | $33.85M | $26.66M | $21.90M | $25.91M | +6.4% |
| Property, plant & equipment | $7.72M | $7.93M | $8.21M | $8.49M | $8.79M | -2.7% |
| Goodwill & intangibles | $9.96M | $10.19M | $10.43M | $10.66M | $10.91M | -2.3% |
| Total assets | $54.03M | $52.25M | $45.59M | $41.17M | $45.70M | +3.4% |
| Total current liabilities | $23.09M | $22.36M | $20.37M | $20.75M | $24.23M | +3.2% |
| Total debt | $5.28M | $5.44M | $5.58M | $5.73M | $5.87M | -2.9% |
| Total liabilities | $34.43M | $33.53M | $34.05M | $34.42M | $37.53M | +2.7% |
| Retained earnings | -$589.23M | -$583.37M | -$577.84M | -$571.37M | -$567.55M | -1.0% |
| Shareholder equity | $19.60M | $18.72M | $11.53M | $6.75M | $8.18M | +4.7% |
| Working capital | $12.94M | $11.49M | $6.29M | $1.16M | $1.68M | +12.6% |
| Net tangible assets | $9.64M | $8.53M | $1.10M | -$3.91M | -$2.73M | +13.1% |
| Shares issued | 97.49M | 95.34M | 91.09M | 86.00M | 85.98M | +2.3% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$5.86M | -$5.53M | -$6.46M | -$3.83M | -$5.82M | — | -6.0% |
| Depreciation & amortisation | $395.00K | $395.00K | $389.00K | $401.00K | $370.00K | — | 0.0% |
| Stock-based compensation | $2.11M | $2.45M | $2.50M | $2.37M | $2.54M | — | -13.8% |
| Change in working capital | -$838.00K | -$1.64M | -$1.99M | -$2.63M | $637.00K | — | +48.9% |
| Operating cash flow | -$3.44M | -$3.97M | -$4.20M | -$3.73M | -$1.78M | — | +13.3% |
| Capital expenditure | -$79.00K | -$70.00K | — | — | — | -$2.00K | -12.9% |
| Investing cash flow | -$79.00K | -$70.00K | $0 | -$23.00K | $0 | — | -12.9% |
| Financing cash flow | $4.72M | $6.95M | $7.74M | $34.00K | $32.00K | — | -32.2% |
| Free cash flow | -$3.52M | -$4.04M | -$4.20M | -$3.76M | -$1.78M | — | +12.8% |
| End cash position | $14.62M | $13.42M | $10.51M | $6.97M | $10.69M | — | +8.9% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $10.97M | +47.0% |
| Next quarter | — | — | $13.75M | +59.1% |
| Current year | — | — | $39.40M | +21.7% |
| Next year | — | — | $53.27M | +35.2% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders21.15%
Held by institutions43.79%
Institutions holding141
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.19
-0.22% from price
SMA 20
1.17
+1.58% from price
SMA 50
1.34
-11.34% from price
SMA 100
1.47
-19.10% from price
SMA 200
1.68
-29.54% from price
EMA 12
1.19
-0.12% from price
EMA 26
1.23
-3.27% from price
EMA 50
1.31
-9.37% from price
RSI (14)
45.5
Neutral
MACD (12,26,9)
-0.04
Hist 0.01
ATR (14)
0.02
2.02% of price
Realised vol 30D
95.6%
Annualised
Bollinger upper
1.25
20, 2σ
Bollinger lower
1.08
20, 2σ
50 / 200 cross
Death
1.34 vs 1.68
Trend bias
Below 200
-29.54%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.56
Less volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
95.6%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-64.2%
Peak to trough
Max drawdown 5Y
-82.1%
Peak to trough
ATR 14
0.02
2.02% of price
Beta (reported)
1.40
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| May 13, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Dec 16, 25 | Citizens | INITIATED | — | Market Outperform |
| Nov 12, 25 | Roth Capital | MAINTAINED | Buy | Buy |
| Mar 5, 24 | Lake Street | MAINTAINED | Buy | Buy |
| Mar 5, 24 | Roth MKM | MAINTAINED | Buy | Buy |
| Jan 10, 24 | Roth MKM | INITIATED | — | Buy |
| Mar 6, 23 | Piper Sandler | MAINTAINED | — | Overweight |
| Mar 6, 23 | Lake Street | MAINTAINED | — | Buy |
| Mar 6, 23 | B. Riley Securities | MAINTAINED | — | Buy |
| Nov 11, 22 | Cowen & Co. | MAINTAINED | — | Outperform |
| Jul 12, 22 | Aegis Capital | INITIATED | — | Buy |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:10
Split dateJul 11, 2012
Headlines
Shares dip with pressure from technology, yields and oil fall
Reuters · 7m ago
Samsung Just Authorized Its Largest Shareholder Return Ever. Every Major Memory Stock Fell Monday.
Motley Fool · 8m ago
Aggreko Announces Filing of Registration Statement for Proposed Initial Public Offering
Business Wire · 9m ago
Nashville hospital admits 4 patients got the wrong drug — 1 was left paralyzed. State caps its payouts at $1M
Moneywise · 9m ago
La Rosa Holdings Corp. Announces Receipt of Nasdaq Deficiency Notice and Subsequent Regaining of Compliance
GlobeNewswire · 9m ago
SBA, Department of Energy Partner to Advance President Trump's American Energy Dominance Agenda
PR Newswire · 10m ago
Data Center Politics Could Help an Unlikely Industry: Bitcoin Miners
Barrons.com · 11m ago
Jeff's Bagel Run opening 11 locations in these 5 states this fall
USA TODAY · 11m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.